These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17019836)

  • 41. Combination antihypertensive therapy.
    Simpson FO
    Cardiovasc Clin; 1971; 2(3):37-54. PubMed ID: 4149975
    [No Abstract]   [Full Text] [Related]  

  • 42. Atenolol and cardiovascular risk: an issue close to the heart.
    Wilkinson IB; McEniery CM; Cockcroft JR
    Lancet; 2006 Feb; 367(9511):627-9. PubMed ID: 16503444
    [No Abstract]   [Full Text] [Related]  

  • 43. [Combined antihypertensive therapy: review of multicenter studies conducted in foreign countries].
    Shabalin AV; Nikitin IuP
    Ter Arkh; 1999; 71(8):74-8. PubMed ID: 10515043
    [No Abstract]   [Full Text] [Related]  

  • 44. [ELSA Studies studies progression of atherosclerosis. Calcium antagonist arrests the process more than a beta-blocker].
    Einecke D
    MMW Fortschr Med; 2001 Jul; 143(26-27):6. PubMed ID: 11481923
    [No Abstract]   [Full Text] [Related]  

  • 45. [Treatment of hypertension in old age].
    Rudaia ES
    Med Sestra; 1985 Oct; 44(10):10-3. PubMed ID: 2871474
    [No Abstract]   [Full Text] [Related]  

  • 46. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
    Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
    Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Spironolactone in the treatment of hypertension: a review.
    Brest AN
    Clin Ther; 1986; 8(5):568-85. PubMed ID: 2876776
    [No Abstract]   [Full Text] [Related]  

  • 48. New and emerging drug treatments for hypertension.
    Krum H; Pellizzer AM
    Aust Fam Physician; 1998 Apr; 27(4):235-7, 240-2. PubMed ID: 9581329
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ethnic differences in blood pressure response to first and second-line antihypertensive therapies in patients randomized in the ASCOT Trial.
    Gupta AK; Poulter NR; Dobson J; Eldridge S; Cappuccio FP; Caulfield M; Collier D; Cruickshank JK; Sever PS; Feder G;
    Am J Hypertens; 2010 Sep; 23(9):1023-30. PubMed ID: 20725056
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Criticism against the atenolol meta-analysis remains].
    Forsén K
    Lakartidningen; 2005 Feb 7-13; 102(6):412, 414; discussion 414-5. PubMed ID: 15754686
    [No Abstract]   [Full Text] [Related]  

  • 51. [Current treatment of arterial hypertension and its complications].
    Teodorescu P; Câmpeanu A
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1976; 28(3):161-9. PubMed ID: 7821
    [No Abstract]   [Full Text] [Related]  

  • 52. The ASCOT trial: a closer look.
    Kaplan NM
    J Hypertens; 2006 Feb; 24(2):211-4. PubMed ID: 16508561
    [No Abstract]   [Full Text] [Related]  

  • 53. Safety and efficacy of first-line antihypertensives.
    Strickland C
    J Fam Pract; 1997 Jun; 44(6):530-1. PubMed ID: 9191619
    [No Abstract]   [Full Text] [Related]  

  • 54. [Treatment of hypertension with urapidil (Ebrantil)].
    Sirakova V; Penkov N; Kaponov Kh
    Vutr Boles; 1986; 25(2):29-32. PubMed ID: 2872754
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Results from the LIFE study: promising effects of new hypertensive agents].
    Nilsson P; Kahan T
    Lakartidningen; 2002 Apr; 99(16):1792-4. PubMed ID: 12043477
    [No Abstract]   [Full Text] [Related]  

  • 56. [Noticeable meta-analysis of atenolol does not cover all aspects].
    Forsén K
    Lakartidningen; 2005 Jan 3-16; 102(1-2):61-3. PubMed ID: 15707110
    [No Abstract]   [Full Text] [Related]  

  • 57. [Clinical effectiveness of cardio-selective blockers associated with small diuretic doses as monotherapy for hypertension].
    Amodeo C
    Arq Bras Cardiol; 1998 Apr; 70(4):289-90. PubMed ID: 9687631
    [No Abstract]   [Full Text] [Related]  

  • 58. Effects of a beta blocker and spironolactone on plasma homocysteine levels.
    Korkmaz ME; Atar I; Tayfun E; Yildirir A; Ulucam M; Ozin B; Muderrisoglu H; Turan M
    Int J Cardiol; 2003 Oct; 91(2-3):259-60. PubMed ID: 14559143
    [No Abstract]   [Full Text] [Related]  

  • 59. Beta-blockers as sub-optimal treatment for hypertension: time for first-line therapy revision?
    Narkiewicz K; Kjeldsen SE; Oparil S; Hedner T
    Blood Press; 2006; 15(6):323-4. PubMed ID: 17472021
    [No Abstract]   [Full Text] [Related]  

  • 60. [Calcium antagonists lower not only blood pressure. Arteriosclerosis is braked too].
    MMW Fortschr Med; 2001 Nov; 143(46):60. PubMed ID: 11759606
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.